F 0755
Level of Harm - Minimal harm
or potential for actual harm
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on review of facility policy and clinical records, it was determined that the facility failed to ensure the
timely availability of medication for three of three residents reviewed (Residents R1, R2, and R3).
Residents Affected - Some
Findings include:
Review of the facility policy entitled Specialty RX Policies and Procedures Pennsylvania dated 5/15/24,
revealed . Each facility has routine deliveries to meet the facility's needs and ensure timelines of medication
availability . Specialty Rx, Inc. pharmacies provide emergency deliveries of medication during and after
normally scheduled hours of pharmacy operation and to ensure the customer is provided medications and
care as ordered by the physician. A stat medication refers to a new medication ordered by the physician or
a true stat that is not available in the facilities Back-up box or E-kit to provide medications in a timely
manner by utilizing satellite (back-up) pharmacies to dispense medications that are needed by a facility
sooner than the facility's regularly scheduled delivery
Resident R1's clinical record revealed an admission date of 12/06/24, with diagnoses that included epilepsy
(a seizure disorder), cerebral palsy (a disorder affecting movement, muscle tone, or posture), and major
depressive disorder.
Resident R1's clinical record revealed a physician's order dated 12/06/24, for Lacosamide (an
anticonvulsant medication used to treat seizures) 150 milligrams (mg) give one tablet two times a day.
Review of Resident R1's December 2024 Medication Administration Record (MAR) revealed the
Lacosamide 150 mg was not administered as ordered by the physician on 12/06/24 (one dose), 12/07/24
(two doses), and 12/08/24 (one dose). Progress notes corresponding with the missed doses indicated the
facility was waiting for the pharmacy to deliver the medications.
Resident R2's clinical record revealed an admission date of 11/29/24, with diagnoses that included
pneumonia (lung infection), chronic obstructive pulmonary disease (a group of lung diseases that make it
difficult to breath), and muscle weakness.
Resident R2's clinical record revealed a physician's order dated 11/29/24, for Cefazolin Sodium Injection
Solution Reconstituted (an antibiotic used to treat various infections) 2 grams every 8 hours intravenously
(medication delivered directly into the bloodstream).
Review of Resident R2's November 2024 MAR and December 2024 MAR revealed the Cefazolin Sodium
Injection Solution Reconstituted 2 grams was not administered as ordered by the physician on 11/30/24
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
395502
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395502
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/31/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Oakwood Heights Village
10 Vo Tech Drive
Oil City, PA 16301
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
(three doses) and on 12/01/24 (one dose). Progress notes corresponding with the missed doses indicated
the facility was waiting for the pharmacy to deliver the medications.
Resident R3's clinical record revealed an admission date of 12/26/24, with diagnoses that included infection
of amputation stump, malignant neoplasm of the left lacrimal and gland (tumor near eye), and iron
deficiency.
Resident R3's clinical record revealed a physician's order dated 12/26/24, for Piperacillin Sodium
Tazobactam Sodium Solution Reconstituted (an antibiotic used to treat various infections) 4.5 grams every
6 hours intravenously.
Review of Resident R3's December 2024 MAR revealed the Piperacillin Sodium Tazobactam Sodium
Solution Reconstituted 4.5 grams was not administered as ordered by the physician on 12/26/24 (two
doses) and 12/27/24 (four doses). Progress notes corresponding with the missed doses indicated the
facility was waiting for the pharmacy to deliver the medications.
During an interview conducted on 12/30/24, at approximately 2:00 p.m. the Director of Nursing confirmed
that the medications for Residents R1, R2, and R3 as listed above were not provided by the pharmacy in a
timely manner, resulting in missed doses.
28 Pa. Code 211.10(c) Resident care policies
28 Pa. Code 211.9(d) Pharmacy services
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395502
If continuation sheet
Page 2 of 2